• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; AORTO UNI-ILIAC [SUPRARENAL]

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; AORTO UNI-ILIAC [SUPRARENAL] Back to Search Results
Model Number A34-34/C100-O20
Device Problems Failure To Adhere Or Bond (1031); Leak/Splash (1354); Material Separation (1562); Torn Material (3024); Unintended Movement (3026)
Patient Problems Aneurysm (1708); Death (1802); Failure of Implant (1924); Ischemia (1942); Occlusion (1984); Rupture (2208)
Event Date 01/15/2017
Event Type  Death  
Manufacturer Narrative
To date the incident sample has not been received for evaluation.If the sample is received or if additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
Patient initially implanted with a bifurcated stent and a suprarenal aortic extension on (b)(6) 2012.It was reported the patient expired on (b)(6) 2017.The physician identified a type 3b endoleak with a crown separation from the suprarenal aortic extension and a ruptured aortic aneurysm.The physician indicated the cause of the patient death is unknown, the physician was not able to determine if it was device related or other concurrent issues.
 
Manufacturer Narrative
At the completion of the complaint investigation, based on the information received, the clinical evaluation was able to confirm the following events; a type 3b endoleak with complete crown separation and a type 1a endoleak.Additionally there was evidence to support the following observations; near complete occlusion of the celiac trunk, near complete occlusion of the sma with dilated small bowel, placement of a right renal artery stent at an unknown date, complete occlusion of the right renal artery stent, and an atrophied non functional right kidney.The clinical evaluation identified the following contributing factors to the reported event; off label use due to patient anatomy, non-endologix stent in the right renal artery, occlusion of the renal stent, possible suboptimal placement of the proximal extension or migration of the device, occlusion of the sma, and occlusion of the celiac trunk.The review of the manufacturing lot confirmed all devices met specifications prior to release.The event devices were not returned for further investigation.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
AORTO UNI-ILIAC [SUPRARENAL]
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key6334832
MDR Text Key67532990
Report Number2031527-2017-00071
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/16/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2015
Device Model NumberA34-34/C100-O20
Device Lot Number1041753-017
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/03/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BIFURCATED- (B)(4)
Patient Outcome(s) Death;
Patient Age73 YR
-
-